NCT06985355 - A Study of MHB046C Injection in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2031

Conditions

Advanced Solid Cancer

Interventions

DRUG

MHB046C

IV administration of MHB046C Q3W; Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and confirmed disease progression.

Trial Locations (1)

Unknown

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou